BMJ:糖尿病前期或与患者未来卒中风险升高相关

2012-06-27 夏沫译 中国医学论坛报

  6月7日,《英国医学杂志》(BMJ)在线发表的一项美国和台湾的联合系统性回顾和荟萃分析显示,糖尿病前期(即糖耐量受损或空腹血糖受损与糖耐量受损并存)可能与患者未来卒中风险增加存在相关关系,但其相对风险变化不大,提示可能存有潜在的混杂因素。   ■ 同期述评   美国经济周期研究所特雷德韦尔(Treadwell)高级研究分析员:此研究结果提示临床医生应为糖尿病前期患者制定预防措施,

  6月7日,《英国医学杂志》(BMJ)在线发表的一项美国和台湾的联合系统性回顾和荟萃分析显示,糖尿病前期(即糖耐量受损或空腹血糖受损与糖耐量受损并存)可能与患者未来卒中风险增加存在相关关系,但其相对风险变化不大,提示可能存有潜在的混杂因素。

  ■ 同期述评

  美国经济周期研究所特雷德韦尔(Treadwell)高级研究分析员:此研究结果提示临床医生应为糖尿病前期患者制定预防措施,包括通过改变患者生活方式预防其进展为糖尿病,及通过药物预防卒中。



    

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1847463, encodeId=a11b184e4634c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Nov 08 21:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4515, encodeId=19d2451558, content=Such an imrpesisve answer! You've beaten us all with that!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=nicole, createdTime=Fri Jul 13 10:11:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061194, encodeId=587a2061194fc, content=<a href='/topic/show?id=af476086640' target=_blank style='color:#2F92EE;'>#未来卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60866, encryptionId=af476086640, topicName=未来卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Sat Nov 24 12:55:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281140, encodeId=498c1281140c9, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Fri Jun 29 00:55:00 CST 2012, time=2012-06-29, status=1, ipAttribution=)]
    2012-11-08 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1847463, encodeId=a11b184e4634c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Nov 08 21:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4515, encodeId=19d2451558, content=Such an imrpesisve answer! You've beaten us all with that!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=nicole, createdTime=Fri Jul 13 10:11:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061194, encodeId=587a2061194fc, content=<a href='/topic/show?id=af476086640' target=_blank style='color:#2F92EE;'>#未来卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60866, encryptionId=af476086640, topicName=未来卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Sat Nov 24 12:55:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281140, encodeId=498c1281140c9, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Fri Jun 29 00:55:00 CST 2012, time=2012-06-29, status=1, ipAttribution=)]
    2012-07-13 nicole

    Such an imrpesisve answer! You've beaten us all with that!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1847463, encodeId=a11b184e4634c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Nov 08 21:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4515, encodeId=19d2451558, content=Such an imrpesisve answer! You've beaten us all with that!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=nicole, createdTime=Fri Jul 13 10:11:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061194, encodeId=587a2061194fc, content=<a href='/topic/show?id=af476086640' target=_blank style='color:#2F92EE;'>#未来卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60866, encryptionId=af476086640, topicName=未来卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Sat Nov 24 12:55:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281140, encodeId=498c1281140c9, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Fri Jun 29 00:55:00 CST 2012, time=2012-06-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1847463, encodeId=a11b184e4634c, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Thu Nov 08 21:55:00 CST 2012, time=2012-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=4515, encodeId=19d2451558, content=Such an imrpesisve answer! You've beaten us all with that!, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=nicole, createdTime=Fri Jul 13 10:11:00 CST 2012, time=2012-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061194, encodeId=587a2061194fc, content=<a href='/topic/show?id=af476086640' target=_blank style='color:#2F92EE;'>#未来卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60866, encryptionId=af476086640, topicName=未来卒中)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e68e415, createdName=juliusluan78, createdTime=Sat Nov 24 12:55:00 CST 2012, time=2012-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281140, encodeId=498c1281140c9, content=<a href='/topic/show?id=455f36085f0' target=_blank style='color:#2F92EE;'>#卒中风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36085, encryptionId=455f36085f0, topicName=卒中风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a8f1167, createdName=wmr111, createdTime=Fri Jun 29 00:55:00 CST 2012, time=2012-06-29, status=1, ipAttribution=)]